UG3TR004047
Cooperative Agreement
Overview
Grant Description
Virtual platforms for genetics evaluation in the medically underserved - project summary
Disparate access to genetic services among ethnic minorities and those with low socioeconomic status has marginalized the most vulnerable populations, particularly children with rare diseases. About one-third of children with rare diseases die before they reach their fifth birthday.
There are significant inequalities in genetic services that children currently receive along the Texas-Mexican border in the Rio Grande Valley (RGV) where many of the citizens are underserved and uninsured. While genomic information to improve health outcomes is being integrated in clinical practice elsewhere in the country, significant barriers exist in this impoverished and medically underresourced region of Texas that prevent delivery of essential genetics evaluation.
Prioritizing equity and inclusion in health care, we propose to implement one of the first academic web-based virtual clinics called ConsultaGene in the underresourced regions of Texas to provide clinical evaluation of pediatric rare diseases through front-line clinics. A multidisciplinary team at University of Texas Health Rio Grande Valley Clinic and Baylor College of Medicine will clinically evaluate 100 'hard to diagnose' children with rare diseases, with goals of accelerating access to care and intervention.
Genome sequencing (GS) will be completed as a first-line test to deliver rapid diagnoses and reduce the time to diagnosis for clinical decision-making. We will also build genomic competency of front-line healthcare providers through use of facial recognition technology and education to expedite referral of pediatric patients with suspected rare diseases.
If successfully modeled at the primary partner site (UG3 phase), the strategy will be implemented at Texas Tech University Health Sciences Center (TTUHSC) in El Paso, along the US-Mexico border (UH3 phase). Our ultimate goal is to advance genetics evaluation of pediatric rare diseases in remote marginalized areas of Texas for improving health outcomes and providing avenues for targeted intervention.
Disparate access to genetic services among ethnic minorities and those with low socioeconomic status has marginalized the most vulnerable populations, particularly children with rare diseases. About one-third of children with rare diseases die before they reach their fifth birthday.
There are significant inequalities in genetic services that children currently receive along the Texas-Mexican border in the Rio Grande Valley (RGV) where many of the citizens are underserved and uninsured. While genomic information to improve health outcomes is being integrated in clinical practice elsewhere in the country, significant barriers exist in this impoverished and medically underresourced region of Texas that prevent delivery of essential genetics evaluation.
Prioritizing equity and inclusion in health care, we propose to implement one of the first academic web-based virtual clinics called ConsultaGene in the underresourced regions of Texas to provide clinical evaluation of pediatric rare diseases through front-line clinics. A multidisciplinary team at University of Texas Health Rio Grande Valley Clinic and Baylor College of Medicine will clinically evaluate 100 'hard to diagnose' children with rare diseases, with goals of accelerating access to care and intervention.
Genome sequencing (GS) will be completed as a first-line test to deliver rapid diagnoses and reduce the time to diagnosis for clinical decision-making. We will also build genomic competency of front-line healthcare providers through use of facial recognition technology and education to expedite referral of pediatric patients with suspected rare diseases.
If successfully modeled at the primary partner site (UG3 phase), the strategy will be implemented at Texas Tech University Health Sciences Center (TTUHSC) in El Paso, along the US-Mexico border (UH3 phase). Our ultimate goal is to advance genetics evaluation of pediatric rare diseases in remote marginalized areas of Texas for improving health outcomes and providing avenues for targeted intervention.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Houston,
Texas
770303411
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 71% from $317,000 to $540,961.
Baylor College Of Medicine was awarded
Virtual Platforms for Genetics Evaluation in the Medically Underserved
Cooperative Agreement UG3TR004047
worth $540,961
from National Center for Advancing Translational Sciences in February 2022 with work to be completed primarily in Houston Texas United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional).
Status
(Complete)
Last Modified 9/20/24
Period of Performance
2/1/22
Start Date
1/31/24
End Date
Funding Split
$541.0K
Federal Obligation
$0.0
Non-Federal Obligation
$541.0K
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UG3TR004047
Transaction History
Modifications to UG3TR004047
Additional Detail
Award ID FAIN
UG3TR004047
SAI Number
UG3TR004047-602663781
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Funding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Awardee UEI
FXKMA43NTV21
Awardee CAGE
9Z482
Performance District
TX-09
Senators
John Cornyn
Ted Cruz
Ted Cruz
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $619,000 | 100% |
Modified: 9/20/24